The company attributed the strong growth across all categories particularly from good sales coming from its power brands like 'Navratna Oil', 'Zandu Balm' and 'Boroplus' antiseptic cream among others.
Besides, the firm's board of directors has proposed a 350% dividend of Rs 3.50 per share to its shareholders.
During the quarter, the firm's income from operations stood at Rs 354.3 crore, 26.43% increase from Rs 280.2 crore recorded in the corresponding quarter previous fiscal.
For the year-ended March 31, 2011, Emami posted a 34.74% jump in its consolidated net profit to Rs 228.7 crore. The firm had a net profit of Rs 169.73 crore in the previous fiscal.
During the fiscal year, the company said its revenue from the overseas markets grew by 27.6% at Rs 174 crore. In the quarter, its international businesses grew by 32.9% with sales at Rs 66 crore.
"While development of new products and new markets continues, thrust is being put on increasing distribution and penetration in existing markets and to develop global brands," Emami said in a statement.
On a standalone basis, the firm's net profit for the quarter ended March 31, 2011 was at Rs 51.64 crore as against Rs 40.1 crore posted in the year-ago period. During the quarter, its income from operations stood at Rs 330.8 crore.
For the year-ended March 31, 2011, the firm posted a standalone net profit of Rs 227.4 crore, 37.5% up from Rs 165.4 crore recorded in the previous fiscal.
During the period, the firm's income from operations on a standalone basis stood at Rs 1,221.1 crore, while it had Rs 1,006.8 crore income in the previous financial year.
During the financial year, the company said it has also floated a 100% owned subsidiary, Emami Overseas FZE at Dubai. The firm acquired 90.6% shares of Pharma Derm SAE Co, Egypt with a manufacturing facility at Borg Al Arab, near Alexandria in Egypt.
Shares of Emami closed at Rs 434 on the Bombay Stock Exchange, up 2.50% from the previous close.